Investigating a new high protein formula for patients on home enteral nutrition
Official title: TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal
Run by Société des Produits Nestlé (SPN) · NCT05429853 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new high-protein formula to see if it helps adults on home enteral nutrition feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 109 (estimated) |
| Sponsor | Société des Produits Nestlé (SPN) Industry-sponsored |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Lille and 1 other locations) |
| Trial ID | NCT05429853 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are currently using a polymeric HPHE product for home enteral nutrition.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have acute intestinal diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentre, prospective, open-label study aims to evaluate the tolerance and quality of life in adult patients undergoing home enteral nutrition (HEN) who are currently using a high protein high energy (HPHE) formula. Participants will switch to the Sondalis® HP 2 kcal formula, with or without fiber, for a duration of two months. The study will assess the evolution of tolerance through a questionnaire and monitor the overall quality of life of the patients. Written consent will be obtained from all eligible participants before inclusion in the study.
Why it matters
Potential benefit: If successful, this study could improve the tolerance and quality of life for patients relying on home enteral nutrition.
How similar studies have gone: While this approach is novel, similar studies have shown promise in improving nutritional tolerance in enteral nutrition patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men or women aged ≥18 years, * Being under EN with polymeric HPHE product with or without fibre (=HPHE), * Stable caloric prescription during HEN for at least one month, * Patient with at least a score of 2 on at least 1 item of tolerance questionnaire, * Investigators' judgement to change to HPHE concentrated, * HEN is planned for ≥ 8 weeks, * Life expectancy ≥ 3 months. * Patient or his/her primary caregiver was required to be able to understand the study and to be fully free to participate in it, * Patient having signed an informed consent, * Patient registered with a social security scheme, * Patient willing to adhere to study procedures, Exclusion Criteria: * Pregnancy or breastfeeding, * Being either under PN or ONS, * Acute intestinal disease such as gastric ulcer, gastritis, gastroparesis, * Patient under prokinetic agents during the study phase, * Patient receiving antibiotic, chemotherapy in the 7 days prior to inclusion, * Patient receiving radiation treatment except head and neck location, * Patient expected to receive chemotherapy or radiation treatment during the study except head and neck location , * Severe infectious disease and/or fever \> 38,5°C, * Emergent hospitalization within last month, * Known allergy or intolerance to any of the Sondalis® HP 2kcal with or without fibre ingredients, * Previous treatment with HPHE concentrated at home (2kcal), * Current participation in another intervention study or participation in a previous study for which exclusion period applies. * Non-compliance with prescription and administration modalities as suspected by investigator and/or by home care provider dietitian
Where it's running
-
Hôpital Claude Huriez
Lille, France Recruiting -
Hôpital de l'Archet
Nice, France Not yet recruiting
Study contacts
- Principal investigator: Stephane SCHNEIDER, Pr — Hôpital de l'Archet
- Study coordinator: Catherine DIVE-POULETTY, Dr
- Email: Catherine.DivePouletty@fr.nestle.com
- Phone: +33(0)1 87 60 39 50
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hospital-based look at infants under 6 months with acute malnutrition
This study follows hospitalized infants under 6 months with acute malnutrition to see how common it is and how they grow during treatment.
-
Preoperative Immunonutrition for bone and soft tissue sarcoma patients
This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
-
Preoperative Oral Nutrition for Frail Elderly Hip Fracture Patients
This observational study tests whether giving preoperative oral nutrition helps frail elderly patients with femur fractures fare better around surgery.
-
Nutritional care for adults with type 2 or drug-induced diabetes who are malnourished or at risk
This observational study will follow adults with type 2 or drug-induced diabetes who are malnourished or at risk to see if taking a diabetes-specific high-calorie, high-protein oral supplement with soluble fiber helps their nutrition, blood sugar, and quality of life.
-
Body composition monitoring for people with IBD starting biologic or JAK inhibitor therapy
This project will use bioelectrical impedance to track lean mass percentage and phase angle over one year in adults with moderate-to-severe Crohn's disease or ulcerative colitis who are starting biologic or JAK inhibitor treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.